The analysis shows a steady increase in respiratory system disease mortality among females in Canada from 2024 to 2028. The values rise from 13.82 thousand in 2024 to 14.46 thousand in 2028. Year-on-year growth rates indicate incremental increases, with a CAGR of 1.13% over this period, suggesting persistent upward trends. Compared to 2023, where the actual data is unavailable, the forecast reflects a continued risk for mortality due to respiratory diseases.
Future trends to watch for include:
- Advancements in medical technology and treatments for respiratory diseases,
- Public health initiatives targeting respiratory health,
- Potential impacts of environmental changes on respiratory disease prevalence.